{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:43:44Z","timestamp":1793551424773,"version":"4.5.0"},"reference-count":195,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014989","name":"Chan Zuckerberg Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.tem.2023.05.002","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T17:32:31Z","timestamp":1687627951000},"page":"430-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":294,"title":["Apolipoprotein E in lipid metabolism and neurodegenerative disease"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-8792","authenticated-orcid":false,"given":"Linda G.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-899X","authenticated-orcid":false,"given":"Zachary M.","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-9275","authenticated-orcid":false,"given":"Roxan A.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-4959","authenticated-orcid":false,"given":"Priyanka S.","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2023.05.002_bb0005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbalip.2015.02.007","article-title":"Measuring brain lipids","volume":"1851","author":"Dawson","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tem.2023.05.002_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12031-007-0060-1","article-title":"Brain uptake and utilization of fatty acids, lipids and lipoproteins: application to neurological disorders","volume":"33","author":"Hamilton","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0015","first-page":"146","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg. Z. Psych. Psych-gerich. Med."},{"key":"10.1016\/j.tem.2023.05.002_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson's disease: proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tem.2023.05.002_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fncel.2019.00175","article-title":"Lipids at the crossroad of \u03b1-synuclein function and dysfunction: biological and pathological implications","volume":"13","author":"Alza","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2016.08.027","article-title":"Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases","volume":"49","author":"Marin","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tem.2023.05.002_bb0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004804","article-title":"Lysosomal lipid storage diseases","volume":"3","author":"Schulze","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.tem.2023.05.002_bb0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3389\/fphys.2020.00393","article-title":"Lipid and lipoprotein metabolism in microglia","volume":"11","author":"Loving","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tem.2023.05.002_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcdb.2020.07.017","article-title":"Lipid metabolism in astrocytic structure and function","volume":"112","author":"Lee","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.tem.2023.05.002_bb0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2023.05.002_bb0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture","volume":"53","author":"Chia","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2023.05.002_bb0060","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1194\/jlr.R800069-JLR200","article-title":"Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS","volume":"50","author":"Mahley","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2023.05.002_bb0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2016.12.001","article-title":"ApoE, ApoE receptors, and the synapse in Alzheimer's disease","volume":"28","author":"Lane-Donovan","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.05.002_bb0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.tem.2023.05.002_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41422-022-00759-y","article-title":"LilrB3 is a putative cell surface receptor of APOE4","volume":"33","author":"Zhou","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.tem.2023.05.002_bb0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/13547500903108423","article-title":"Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease","volume":"14","author":"Roher","year":"2009","journal-title":"Biomarkers"},{"key":"10.1016\/j.tem.2023.05.002_bb0090","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2023.05.002_bb0095","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/glia.23974","article-title":"Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation","volume":"69","author":"Lanfranco","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.tem.2023.05.002_bb0100","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","article-title":"APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes","volume":"611","author":"Blanchard","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.05.002_bb0105","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41591-020-0886-4","article-title":"Reconstruction of the human blood\u2013brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes","volume":"26","author":"Blanchard","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2023.05.002_bb0110","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00005072-199603000-00013","article-title":"Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease","volume":"55","author":"Metzger","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0120","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/nbdi.1999.0251","article-title":"Apolipoprotein E expression by neurons surviving excitotoxic stress","volume":"6","author":"Boschert","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tem.2023.05.002_bb0125","first-page":"106","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.tem.2023.05.002_bb0135","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to \u03b2-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2023.05.002_bb0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00401-017-1685-y","article-title":"Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers","volume":"133","author":"Deming","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tem.2023.05.002_bb0145","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer's disease: progress to date and the path forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.tem.2023.05.002_bb0150","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2023.05.002_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature15394","article-title":"An integrated map of structural variation in 2,504 human genomes","volume":"526","author":"Sudmant","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.05.002_bb0160","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.05.002_bb0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI113096","article-title":"Apolipoprotein E2-Christchurch (136 Arg\u2013Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia","volume":"80","author":"Wardell","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2023.05.002_bb0170","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2023.05.002_bb0175","first-page":"937","article-title":"Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia","volume":"52","author":"Van den Maagdenberg","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tem.2023.05.002_bb0180","doi-asserted-by":"crossref","first-page":"eabc9375","DOI":"10.1126\/scitranslmed.abc9375","article-title":"APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tem.2023.05.002_bb0185","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamaneurol.2022.1166","article-title":"Association of rare APOE missense variants V236E and R251G with risk of Alzheimer disease","volume":"79","author":"Le Guen","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jama.1997.03550020068040","article-title":"Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing","volume":"278","author":"Jordan","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2023.05.002_bb0195","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/brain\/awh595","article-title":"The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study","volume":"128","author":"Teasdale","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.tem.2023.05.002_bb0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-016-1580-y","article-title":"Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease","volume":"132","author":"Shinohara","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tem.2023.05.002_bb0205","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410380219","article-title":"Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy","volume":"38","author":"Greenberg","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0210","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamaneurol.2014.681","article-title":"Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease","volume":"71","author":"Ringman","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0215","first-page":"2083","article-title":"Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease","volume":"148","author":"Premkumar","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tem.2023.05.002_bb0220","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamaneurol.2022.1634","article-title":"Association of APOE genotypes and chronic traumatic encephalopathy","volume":"79","author":"Atherton","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11682-016-9552-3","article-title":"Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment","volume":"11","author":"Amidi","year":"2017","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.tem.2023.05.002_bb0230","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1200\/JCO.18.00140","article-title":"Cancer-related cognitive outcomes among older breast cancer survivors in the Thinking and Living With Cancer study","volume":"36","author":"Mandelblatt","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tem.2023.05.002_bb0235","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.3390\/cancers12123842","article-title":"Cancer chemotherapy related cognitive impairment and the impact of the Alzheimer's disease risk factor APOE","volume":"12","author":"Fernandez","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tem.2023.05.002_bb0240","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3945\/ajcn.112.043240","article-title":"APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults","volume":"96","author":"Carvalho-Wells","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tem.2023.05.002_bb0245","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-2275(20)41611-6","article-title":"Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis","volume":"33","author":"Dallongeville","year":"1992","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2023.05.002_bb0250","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2023.05.002_bb0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s40478-021-01302-7","article-title":"APOE \u03b54 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study","volume":"9","author":"Kurki","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tem.2023.05.002_bb0260","doi-asserted-by":"crossref","first-page":"13483","DOI":"10.1038\/s41598-022-17262-4","article-title":"The association of APOE genotype with COVID-19 disease severity","volume":"12","author":"Safdari Lord","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2023.05.002_bb0265","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41586-022-05344-2","article-title":"Common human genetic variants of APOE impact murine COVID-19 mortality","volume":"611","author":"Ostendorf","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.05.002_bb0270","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62199","article-title":"APOE2 is associated with longevity independent of Alzheimer's disease","volume":"9","author":"Shinohara","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.tem.2023.05.002_bb0275","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/0003-4819-98-5-623","article-title":"NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment","volume":"98","author":"Brewer","year":"1983","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2023.05.002_bb0280","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","article-title":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders","volume":"94","author":"Mahley","year":"2016","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.tem.2023.05.002_bb0285","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1086\/301901","article-title":"Genetic association of apolipoprotein E with age-related macular degeneration","volume":"63","author":"Klaver","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tem.2023.05.002_bb0290","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41591-020-0879-3","article-title":"Common germline variants of the human APOE gene modulate melanoma progression and survival","volume":"26","author":"Ostendorf","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2023.05.002_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102954","article-title":"Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank","volume":"59","author":"Lumsden","year":"2020","journal-title":"eBioMedicine"},{"key":"10.1016\/j.tem.2023.05.002_bb0300","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41398-021-01518-0","article-title":"Heterogeneous effects of genetic risk for Alzheimer's disease on the phenome","volume":"11","author":"Wu","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tem.2023.05.002_bb0305","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-021-00483-y","article-title":"APO\u03954 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis","volume":"16","author":"Farmer","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tem.2023.05.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112196","article-title":"APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge","volume":"42","author":"Lee","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2023.05.002_bb0315","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","article-title":"Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity","volume":"29","author":"Victor","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tem.2023.05.002_bb0320","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer's disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.tem.2023.05.002_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108224","article-title":"PICALM rescues endocytic defects caused by the Alzheimer's disease risk factor APOE4","volume":"33","author":"Narayan","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2023.05.002_bb0330","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.stemcr.2021.11.007","article-title":"APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes","volume":"17","author":"de Leeuw","year":"2022","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.tem.2023.05.002_bb0335","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fnins.2017.00702","article-title":"The endosomal-lysosomal pathway is dysregulated by APOE4 expression in vivo","volume":"11","author":"Nuriel","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0340","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","article-title":"Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2023.05.002_bb0345","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2023.05.002_bb0350","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt\u2013Jakob disease","volume":"541","author":"Namba","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.tem.2023.05.002_bb0355","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","article-title":"Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein","volume":"333","author":"Polvikoski","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2023.05.002_bb0360","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","article-title":"Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model","volume":"47","author":"Holtzman","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0365","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","article-title":"Cholesterol and matrisome pathways dysregulated in astrocytes and microglia","volume":"185","author":"Tcw","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tem.2023.05.002_bb0370","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tem.2023.05.002_bb0375","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/cells8020182","article-title":"Apolipoprotein E4 alters astrocyte fatty acid metabolism and lipid droplet formation","volume":"8","author":"Farmer","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.tem.2023.05.002_bb0380","doi-asserted-by":"crossref","first-page":"eaaz4564","DOI":"10.1126\/scitranslmed.aaz4564","article-title":"APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia","volume":"13","author":"Sienski","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tem.2023.05.002_bb0385","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","article-title":"Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain","volume":"23","author":"Marschallinger","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0390","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2023.05.002_bb0395","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1093\/brain\/awab478","article-title":"APOE4 derived from astrocytes leads to blood-brain barrier impairment","volume":"145","author":"Jackson","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.tem.2023.05.002_bb0400","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1038\/s41467-018-06301-2","article-title":"Apo\u03b54 disrupts neurovascular regulation and undermines white matter integrity and cognitive function","volume":"9","author":"Koizumi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2023.05.002_bb0405","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-021-00073-z","article-title":"APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer's mice via cyclophilin A independently of amyloid-\u03b2","volume":"1","author":"Montagne","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.tem.2023.05.002_bb0410","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","article-title":"Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits","volume":"3","author":"Koutsodendris","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.tem.2023.05.002_bb0415","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-020-00366-8","article-title":"Cerebrovascular amyloid angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in apolipoprotein E","volume":"15","author":"Robert","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tem.2023.05.002_bb0420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.05.002_bb0425","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","article-title":"The glia\u2013neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in glia via APOE\/D","volume":"26","author":"Liu","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.05.002_bb0430","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","article-title":"Neuron\u2013astrocyte metabolic coupling protects against activity-induced fatty acid toxicity","volume":"177","author":"Ioannou","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tem.2023.05.002_bb0435","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112095118","article-title":"Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer's disease-associated genes","volume":"118","author":"Moulton","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2023.05.002_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108572","article-title":"ApoE4 impairs neuron\u2013astrocyte coupling of fatty acid metabolism","volume":"34","author":"Qi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2023.05.002_bb0445","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1038\/s41467-020-17514-9","article-title":"Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model","volume":"11","author":"Guttenplan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2023.05.002_bb0450","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.05.002_bb0455","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","article-title":"Neurotoxic reactive astrocytes induce cell death via saturated lipids","volume":"599","author":"Guttenplan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.05.002_bb0460","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2009.05917.x","article-title":"Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats","volume":"109","author":"Nieweg","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tem.2023.05.002_bb0465","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","article-title":"Cholesterol metabolism in neurons and astrocytes","volume":"50","author":"Pfrieger","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.tem.2023.05.002_bb0470","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.stem.2018.12.013","article-title":"Cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-\u03b2 in iPSC-derived Alzheimer's disease neurons","volume":"24","author":"van der Kant","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tem.2023.05.002_bb0475","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jnen\/nlac054","article-title":"Apolipoprotein E \u03b54 mediates myelin breakdown by targeting oligodendrocytes in sporadic Alzheimer disease","volume":"81","author":"Cheng","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0480","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/S0021-9258(19)69553-0","article-title":"Metabolism of chromatographically separated rat serum lipoproteins specifically labeled with 125I-apolipoprotein E","volume":"256","author":"van't Hooft","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2023.05.002_bb0485","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain","volume":"262","author":"Pitas","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2023.05.002_bb0490","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.9250","article-title":"Association of apolipoprotein E in lipoprotein subspecies with risk of dementia","volume":"3","author":"Koch","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tem.2023.05.002_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104724","article-title":"APOE in the normal brain","volume":"136","author":"Flowers","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tem.2023.05.002_bb0500","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tem.2016.03.018","article-title":"LXR regulation of brain cholesterol: from development to disease","volume":"27","author":"Courtney","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.05.002_bb0505","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jnen\/nlw067","article-title":"Apolipoprotein E genotype affects size of apoE complexes in cerebrospinal fluid","volume":"75","author":"Heinsinger","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0510","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","article-title":"Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and A\u03b2 metabolism in apoE4-targeted replacement mice","volume":"10","author":"Hu","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tem.2023.05.002_bb0515","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1021\/bi701923h","article-title":"Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms","volume":"47","author":"Sakamoto","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.tem.2023.05.002_bb0520","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1021\/bi1017655","article-title":"Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4","volume":"49","author":"Nguyen","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.tem.2023.05.002_bb0525","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0022-2275(20)42621-5","article-title":"Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine\u2013arginine interchange at residue 112","volume":"31","author":"Weisgraber","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2023.05.002_bb0530","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","article-title":"Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture","volume":"74","author":"Michikawa","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tem.2023.05.002_bb0535","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/jnr.22073","article-title":"Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture","volume":"87","author":"Minagawa","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tem.2023.05.002_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110435","article-title":"Isoform- and cell-state-specific lipidation of ApoE in astrocytes","volume":"38","author":"Lindner","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2023.05.002_bb0545","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1242\/jcs.060681","article-title":"Cholesterol reduction impairs exocytosis of synaptic vesicles","volume":"123","author":"Linetti","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tem.2023.05.002_bb0550","doi-asserted-by":"crossref","first-page":"17068","DOI":"10.1523\/JNEUROSCI.4067-10.2010","article-title":"Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration","volume":"30","author":"Liu","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0555","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2007.08.008","article-title":"Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1","volume":"56","author":"Liu","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tem.2023.05.002_bb0560","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","article-title":"Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels","volume":"28","author":"Riddell","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113088","article-title":"Metabolomics study to identify plasma biomarkers in Alzheimer disease: ApoE genotype effect","volume":"180","author":"Pe\u00f1a-Bautista","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.tem.2023.05.002_bb0570","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41467-020-14959-w","article-title":"Sex and APOE \u03b54 genotype modify the Alzheimer's disease serum metabolome","volume":"11","author":"Arnold","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2023.05.002_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108132","article-title":"Cell-type- and brain-region-resolved mouse brain lipidome","volume":"32","author":"Fitzner","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2023.05.002_bb0580","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","article-title":"TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge","volume":"105","author":"Nugent","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.tem.2023.05.002_bb0585","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1038\/s41598-020-61142-8","article-title":"APOE4 is associated with differential regional vulnerability to bioenergetic deficits in aged APOE mice","volume":"10","author":"Area-Gomez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2023.05.002_bb0590","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neuron.2020.02.034","article-title":"Alzheimer's risk factors age, APOE genotype, and sex drive distinct molecular pathways","volume":"106","author":"Zhao","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.tem.2023.05.002_bb0595","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41398-022-01881-6","article-title":"Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice","volume":"12","author":"Miranda","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tem.2023.05.002_bb0600","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11306-019-1627-x","article-title":"Cerebrospinal fluid lipidomics: effects of an intravenous triglyceride infusion and apoE status","volume":"16","author":"Hanson","year":"2019","journal-title":"Metabolomics"},{"key":"10.1016\/j.tem.2023.05.002_bb0605","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.neurobiolaging.2007.07.024","article-title":"ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain","volume":"30","author":"Bandaru","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tem.2023.05.002_bb0610","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/alz.12800","article-title":"Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains","volume":"19","author":"Novotny","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tem.2023.05.002_bb0615","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","article-title":"Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia","volume":"109","author":"Wang","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.tem.2023.05.002_bb0620","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/humc.2017.231","article-title":"AAVrh.10-mediated APOE2 central nervous system gene therapy for APOE4-associated Alzheimer's disease","volume":"29","author":"Rosenberg","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.tem.2023.05.002_bb0625","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2016.04.020","article-title":"Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models","volume":"44","author":"Zhao","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tem.2023.05.002_bb0630","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI27883","article-title":"Liver X receptors as integrators of metabolic and inflammatory signaling","volume":"116","author":"Zelcer","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2023.05.002_bb0635","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbalip.2011.09.014","article-title":"The retinoid X receptors and their ligands","volume":"1821","author":"Dawson","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tem.2023.05.002_bb0640","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1326-5-44","article-title":"Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-\u03b2 peptides in the cerebral spinal fluid of rats","volume":"5","author":"Suon","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tem.2023.05.002_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172161","article-title":"Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice","volume":"12","author":"Carter","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2023.05.002_bb0650","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1523\/JNEUROSCI.5198-13.2014","article-title":"Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene","volume":"34","author":"Boehm-Cagan","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0655","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-150029","article-title":"The continuing failure of bexarotene in Alzheimer's disease mice","volume":"46","author":"Balducci","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tem.2023.05.002_bb0660","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2015.04.020","article-title":"Lack of support for bexarotene as a treatment for Alzheimer's disease","volume":"100","author":"O'Hare","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tem.2023.05.002_bb0665","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-8-18","article-title":"Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP\/PS1 mice","volume":"8","author":"LaClair","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tem.2023.05.002_bb0670","doi-asserted-by":"crossref","first-page":"11862","DOI":"10.1523\/JNEUROSCI.1001-15.2015","article-title":"Bexarotene-activated retinoid X receptors regulate neuronal differentiation and dendritic complexity","volume":"35","author":"Mounier","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0675","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.trci.2016.06.001","article-title":"A randomized controlled study to evaluate the effect of bexarotene on amyloid-\u03b2 and apolipoprotein E metabolism in healthy subjects","volume":"2","author":"Ghosal","year":"2016","journal-title":"Alzheimer's Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.tem.2023.05.002_bb0680","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13195-016-0173-2","article-title":"Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tem.2023.05.002_bb0685","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1194\/jlr.M500116-JLR200","article-title":"Synthetic LXR agonists increase LDL in CETP species","volume":"46","author":"Groot","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tem.2023.05.002_bb0690","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmet.2016.07.016","article-title":"Beneficial and adverse effects of an LXR agonist on human lipid and lipoprotein metabolism and circulating neutrophils","volume":"24","author":"Kirchgessner","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.05.002_bb0695","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/mp.2009.72","article-title":"Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe\/PSEN1DeltaE9 mouse model of Alzheimer's disease","volume":"15","author":"Toledo","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tem.2023.05.002_bb0700","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2006.01.018","article-title":"Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice","volume":"199","author":"Pedersen","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0705","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1523\/JNEUROSCI.3348-08.2008","article-title":"Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist","volume":"28","author":"Nicolakakis","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0710","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.tem.2023.05.002_bb0715","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2010.229","article-title":"A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease","volume":"68","author":"Geldmacher","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0720","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000318845","article-title":"Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study","volume":"30","author":"Gold","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.tem.2023.05.002_bb0725","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3233\/JAD-160467","article-title":"ABCA1 agonist reverses the ApoE4-driven cognitive and brain pathologies","volume":"54","author":"Boehm-Cagan","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tem.2023.05.002_bb0730","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13195-022-01028-1","article-title":"Effect of the ABCA1 agonist CS-6253 on amyloid-\u03b2 and lipoprotein metabolism in cynomolgus monkeys","volume":"14","author":"Noveir","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tem.2023.05.002_bb0735","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-017-0237-y","article-title":"Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease","volume":"9","author":"Geifman","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tem.2023.05.002_bb0740","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3390\/nu9080815","article-title":"Neuroprotective actions of dietary choline","volume":"9","author":"Blusztajn","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.tem.2023.05.002_bb0745","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13037","article-title":"Lifelong choline supplementation ameliorates Alzheimer's disease pathology and associated cognitive deficits by attenuating microglia activation","volume":"18","author":"Velazquez","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.tem.2023.05.002_bb0750","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1038\/s41380-018-0322-z","article-title":"Maternal choline supplementation ameliorates Alzheimer's disease pathology by reducing brain homocysteine levels across multiple generations","volume":"25","author":"Velazquez","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tem.2023.05.002_bb0755","first-page":"17","article-title":"Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature","volume":"9","author":"Conant","year":"2004","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.tem.2023.05.002_bb0760","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/ajcn\/nqac193","article-title":"Is dietary choline intake related to dementia and Alzheimer's disease risks? Results from the Framingham Heart Study","volume":"116","author":"Yuan","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tem.2023.05.002_bb0765","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1749-6632.1996.tb34452.x","article-title":"Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factorsa","volume":"777","author":"Cacabelos","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tem.2023.05.002_bb0770","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0047-6374(01)00310-4","article-title":"Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?","volume":"122","author":"Amenta","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.tem.2023.05.002_bb0775","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3928\/0048-5713-19870301-09","article-title":"A review of recent clinical trials in the treatment of Alzheimer's dementia","volume":"17","author":"Maurice","year":"1987","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.tem.2023.05.002_bb0780","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1358\/mf.1999.21.9.795632","article-title":"Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion","volume":"21","author":"Alvarez","year":"1999","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.tem.2023.05.002_bb0785","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fnmol.2018.00454","article-title":"Effects of APOE genotype on brain proteomic network and cell type changes in Alzheimer's disease","volume":"11","author":"Dai","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0790","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3233\/JAD-200338","article-title":"Alzheimer's disease susceptibility gene apolipoprotein E (APOE) and blood biomarkers in UK Biobank (N=395,769)","volume":"76","author":"Ferguson","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tem.2023.05.002_bb0795","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-biodatasci-011420-031537","article-title":"Spatial metabolomics and imaging mass spectrometry in the age of artificial intelligence","volume":"3","author":"Alexandrov","year":"2020","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"10.1016\/j.tem.2023.05.002_bb0800","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.drudis.2022.02.018","article-title":"Recent advances in metabolomics analysis for early drug development","volume":"27","author":"Alarcon-Barrera","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tem.2023.05.002_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047760","article-title":"The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes)","volume":"7","author":"McIntosh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2023.05.002_bb0810","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/303070","article-title":"Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism","volume":"67","author":"Fullerton","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tem.2023.05.002_bb0815","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1086\/381662","article-title":"Meat-adaptive genes and the evolution of slower aging in humans","volume":"79","author":"Finch","year":"2004","journal-title":"Q. Rev. Biol."},{"key":"10.1016\/j.tem.2023.05.002_bb0820","first-page":"1508","article-title":"Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden","volume":"31","author":"Trumble","year":"2017","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.tem.2023.05.002_bb0825","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.mehy.2006.09.036","article-title":"Role of apolipoprotein E4 in protecting children against early childhood diarrhea outcomes and implications for later development","volume":"68","author":"Ori\u00e1","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.tem.2023.05.002_bb0830","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-020-00740-0","article-title":"The association of APOE \u03b54 with cognitive function over the adult life course and incidence of dementia: 20years follow-up of the Whitehall II study","volume":"13","author":"Gharbi-Meliani","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tem.2023.05.002_bb0835","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68231","article-title":"APOE4 is associated with elevated blood lipids and lower levels of innate immune biomarkers in a tropical Amerindian subsistence population","volume":"10","author":"Garcia","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.tem.2023.05.002_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2015.11.002","article-title":"Role of lipids in the metabolism and activation of immune cells","volume":"34","author":"Hubler","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.tem.2023.05.002_bb0845","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.3390\/ijms19124058","article-title":"The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases","volume":"19","author":"Bernardi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2023.05.002_bb0850","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1469-1809.1999.6340301.x","article-title":"Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?","volume":"63","author":"Corbo","year":"1999","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.tem.2023.05.002_bb0855","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1017\/S0029665112000249","article-title":"ApoE genotype: from geographic distribution to function and responsiveness to dietary factors","volume":"71","author":"Egert","year":"2012","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.tem.2023.05.002_bb0860","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajpa.21298","article-title":"Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history","volume":"143","author":"Eisenberg","year":"2010","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.tem.2023.05.002_bb0865","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/archneurol.2011.646","article-title":"A comprehensive genetic association study of Alzheimer disease in African Americans","volume":"68","author":"Logue","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0870","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jalz.2019.07.016","article-title":"Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics","volume":"15","author":"Blue","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tem.2023.05.002_bb0875","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41380-022-01729-x","article-title":"Global and local ancestry modulate APOE association with Alzheimer's neuropathology and cognitive outcomes in an admixed sample","volume":"27","author":"Naslavsky","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tem.2023.05.002_bb0880","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007791","article-title":"Ancestral origin of ApoE \u03b54 Alzheimer disease risk in Puerto Rican and African American populations","volume":"14","author":"Rajabli","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tem.2023.05.002_bb0885","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1002\/alz.12573","article-title":"APOE genotype, hippocampus, and cognitive markers of Alzheimer's disease in American Indians: data from the Strong Heart Study","volume":"18","author":"Suchy-Dicey","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tem.2023.05.002_bb0890","doi-asserted-by":"crossref","first-page":"13620","DOI":"10.1038\/s41598-022-18033-x","article-title":"Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis","volume":"12","author":"Chen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2023.05.002_bb0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009977","article-title":"A locus at 19q13.31 significantly reduces the ApoE \u03b54 risk for Alzheimer's disease in African ancestry","volume":"18","author":"Rajabli","year":"2022","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tem.2023.05.002_bb0900","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","article-title":"Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis","volume":"74","author":"Neu","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tem.2023.05.002_bb0905","doi-asserted-by":"crossref","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","article-title":"Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis","volume":"272","author":"Sullivan","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2023.05.002_bb0910","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation","volume":"88","author":"Linton","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2023.05.002_bb0915","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","article-title":"Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function","volume":"25","author":"Liu","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0920","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.1523\/JNEUROSCI.1054-16.2016","article-title":"Genetic restoration of plasma ApoE improves cognition and partially restores synaptic defects in ApoE-deficient mice","volume":"36","author":"Lane-Donovan","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0925","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-019-0337-1","article-title":"Lack of hepatic apoE does not influence early A\u03b2 deposition: observations from a new APOE knock-in model","volume":"14","author":"Huynh","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tem.2023.05.002_bb0930","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12974-021-02256-2","article-title":"High-fat diet increases gliosis and immediate early gene expression in APOE3 mice, but not APOE4 mice","volume":"18","author":"Jones","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tem.2023.05.002_bb0935","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3121\/cmr.2010.894","article-title":"A pilot study of gene\/gene and gene\/environment interactions in Alzheimer disease","volume":"9","author":"Ghebranious","year":"2011","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.tem.2023.05.002_bb0940","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/WAD.0000000000000013","article-title":"Gene\u2013environment interaction of body mass index and apolipoprotein E \u03b54 allele on cognitive decline","volume":"28","author":"Rajan","year":"2014","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.tem.2023.05.002_bb0945","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41598-022-05763-1","article-title":"APOE genetics influence murine gut microbiome","volume":"12","author":"Zajac","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2023.05.002_bb0950","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1096\/fj.201900071R","article-title":"APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology","volume":"33","author":"Tran","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.tem.2023.05.002_bb0955","doi-asserted-by":"crossref","first-page":"eadd1236","DOI":"10.1126\/science.add1236","article-title":"ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy","volume":"379","author":"Seo","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.tem.2023.05.002_bb0960","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-019-0352-2","article-title":"Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice","volume":"14","author":"Maldonado Weng","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tem.2023.05.002_bb0965","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.2174\/0929867324666170216113756","article-title":"Gut\u2013brain axis: role of lipids in the regulation of inflammation, pain and CNS Diseases","volume":"25","author":"Russo","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tem.2023.05.002_bb0970","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.619051","article-title":"APOE-\u03b54 carrier status and gut microbiota dysbiosis in patients with Alzheimer disease","volume":"15","author":"Hou","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tem.2023.05.002_bb0975","article-title":"APOE4 drives transcriptional heterogeneity and maladaptive immunometabolic responses of astrocytes","author":"Lee","year":"2023","journal-title":"bioRxiv"}],"container-title":["Trends in Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023000929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023000929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:44:39Z","timestamp":1760906679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276023000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":195,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1043276023000929"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2023.05.002","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein E in lipid metabolism and neurodegenerative disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2023.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}